Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-28 @ 5:21 AM
Study NCT ID:
NCT01567735
Status:
COMPLETED
Last Update Posted:
2017-07-07
First Post:
2012-01-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients
Sponsor:
Janssen R&D Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-24
First Submit QC Date:
None
Study First Post Date:
2012-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-05
Last Update Post Date:
2017-07-07
Last Update Post Date Type:
ACTUAL